Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial

PURPOSE: Pembrolizumab is active in melanoma, but activity in patients with untreated brain metastasis is less established. We present long-term follow-up of pembrolizumab-treated patients with new or progressing brain metastases treated on a phase II clinical trial (ClinicalTrials.gov identifier: N...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Kluger, Harriet M., Chiang, Veronica, Mahajan, Amit, Zito, Christopher R., Sznol, Mario, Tran, Thuy, Weiss, Sarah A., Cohen, Justine V., Yu, James, Hegde, Upendra, Perrotti, Elizabeth, Anderson, Gail, Ralabate, Amanda, Kluger, Yuval, Wei, Wei, Goldberg, Sarah B., Jilaveanu, Lucia B.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2019
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6354772/
https://ncbi.nlm.nih.gov/pubmed/30407895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.00204
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados